Literature DB >> 3925407

Experimental tongue carcinoma of rats induced by oral administration of 4-nitroquinoline 1-oxide (4NQO) in drinking water.

M Ohne, T Satoh, S Yamada, H Takai.   

Abstract

Oral administration of 0.001% 4NQO in drinking water resulted in a high incidence of tongue carcinoma in rats. In other major organs, tumor induction was rarely observed. The most frequent site of tongue carcinoma was the dorsum. No metastases were found. Changes observed included carcinoma in situ and invasive carcinoma. Carcinoma in situ showed erosion, leukoplakia, and a gross papillary appearance. Histologically, most carcinomas in situ showed full-thickness alteration of epithelium. Some carcinomas in situ in papillary lesions showed slightly less than full-thickness alteration of epithelium, exhibiting downward, well-differentiated growth. Invasive carcinomas were either endophytic or exophytic. Histologic grading of invasive carcinoma varied from highly to poorly differentiated. The method described offers a new experimental animal model of tongue carcinoma.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3925407     DOI: 10.1016/0030-4220(85)90189-6

Source DB:  PubMed          Journal:  Oral Surg Oral Med Oral Pathol        ISSN: 0030-4220


  12 in total

1.  The effect of desalivation on the malignant transformation of the tongue epithelium and associated stromal myofibroblasts in a rat 4-nitroquinoline 1-oxide-induced carcinogenesis model.

Authors:  Marilena Vered; Osnat Grinstein-Koren; Shoshana Reiter; Irit Allon; Dan Dayan
Journal:  Int J Exp Pathol       Date:  2010-03-26       Impact factor: 1.925

2.  Abnormal expression of bcl-2 and bax in rat tongue mucosa during the development of squamous cell carcinoma induced by 4-nitroquinoline 1-oxide.

Authors:  Daniel A Ribeiro; Daisy M F Salvadori; Mariângela E A Marques
Journal:  Int J Exp Pathol       Date:  2005-12       Impact factor: 1.925

3.  The use of animal models for cancer chemoprevention drug development.

Authors:  Vernon E Steele; Ronald A Lubet
Journal:  Semin Oncol       Date:  2010-08       Impact factor: 4.929

4.  Genomic instability in blood cells is able to predict the oral cancer risk: an experimental study in rats.

Authors:  Daniel A Ribeiro; Daniela G Grilli; Daisy M F Salvadori
Journal:  J Mol Histol       Date:  2008-08-01       Impact factor: 2.611

5.  Assessment of bromodeoxyuridine-labeled S-phase cells in experimentally induced precancerous lesions in the rat's tongue.

Authors:  Y Yamamoto; T Itoh; H Takahashi
Journal:  Eur Arch Otorhinolaryngol       Date:  1994       Impact factor: 2.503

6.  FDG-PET/CT of head and neck squamous cell carcinoma in a rat model.

Authors:  Karine Aubry; Ziyang Shao; Jacques Monteil; François Paraf; Jean Pierre Bessède; Michel Rigaud
Journal:  Mol Imaging Biol       Date:  2008-11-25       Impact factor: 3.488

7.  Diffusion Reflection Method for Early Detection of Oral Squamous Cell Carcinoma Specifically Targeted by Circulating Gold-Nanorods Bio-Conjugated to Anti-Epidermal Growth Factor Receptor.

Authors:  Dror Fixler; Abraham Hirshberg; Shiran Sudri; Hamootal Duadi; Florin Altman; Irit Allon; Ariel Ashkenazy; Ruchira Chakraborty; Ilya Novikov
Journal:  Int J Nanomedicine       Date:  2021-03-17

8.  Gingival changes in wistar rats after oral treatment with 4-nitroquinoline 1-oxide.

Authors:  Daniel Araki Ribeiro; Daisy Maria Fávero Salvadori
Journal:  Eur J Dent       Date:  2007-07

9.  Response of lymphocyte subsets and cytokines to Shenyang prescription in Sprague-Dawley rats with tongue squamous cell carcinomas induced by 4NQO.

Authors:  Canhua Jiang; Dongxia Ye; Weiliu Qiu; Xiuli Zhang; Zhiyuan Zhang; Di He; Ping Zhang; Wantao Chen
Journal:  BMC Cancer       Date:  2007-03-05       Impact factor: 4.430

10.  Isolation of differentiated squamous and undifferentiated spindle carcinoma cell lines with differing metastatic potential from a 4-nitroquinoline N-Oxide-induced tongue carcinoma in a F344 rat.

Authors:  S Takeuchi; H Nakanishi; K Yoshida; S Yamamoto; H Tonoki; T Tsukamoto; S Fukushima; T Moriuchi; K Kurita; M Tatematsu
Journal:  Jpn J Cancer Res       Date:  2000-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.